Skip to main content
. 2021 Feb 25;13(5):958. doi: 10.3390/cancers13050958

Figure 1.

Figure 1

Idasanutlin concentration-dependently activates p53 in human macrophages. (A) Western analysis and quantification of p53 and CDKN1A (p21) protein expression in macrophages exposed to indicated concentrations of RG7388 for 24 h (n = 4). (B) mRNA expression of indicated p53 target genes in macrophages treated with different concentrations of RG7388 for 24 h (n = 3).